Company Filing History:
Years Active: 1995-1996
Title: The Innovations of David C Spellmeyer
Introduction
David C Spellmeyer is a notable inventor based in Alameda, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with opioid and adrenergic receptors. With a total of 3 patents to his name, Spellmeyer has established himself as a key figure in his area of expertise.
Latest Patents
Among his latest patents, Spellmeyer has developed opiate receptor ligands, which are compounds designed to bind to opioid receptors. These compounds are represented by the formula: ##STR1## wherein X and Y are each independently ##STR2##. Additionally, he has worked on peptoid α-1 adrenergic receptor ligands, which are useful for treating conditions modulated by α1-adrenergic receptors, represented by the formula: ##STR1##.
Career Highlights
Spellmeyer is currently associated with Chiron Corporation, where he continues to innovate and contribute to the pharmaceutical industry. His work has been instrumental in advancing the understanding and treatment of various medical conditions.
Collaborations
Throughout his career, Spellmeyer has collaborated with esteemed colleagues, including Walter H Moos and Eric J Martin. These partnerships have further enhanced his research and development efforts.
Conclusion
David C Spellmeyer is a distinguished inventor whose work in the field of pharmaceuticals has led to significant advancements. His innovative patents and collaborations reflect his commitment to improving medical treatments and understanding complex biological systems.